)
Edge28 Nov 2025
Keeping the Streak Alive: The Story of Duolingo
How Duolingo made language learning addictive, scaled to millions of users, and built a powerful subscription business around everyday practice.
ChemoMetec (CHEMM) investor relations material
ChemoMetec Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary7 Nov, 2025
Executive summary
Revenue increased by 8% year-over-year in Q1 2025/26 to DKK 124.6 million (11% in constant currency), with strong growth in instruments, consumables, and services sales.
EBITDA reached DKK 68.8 million, with a margin of 55%, up from 54% in the same period last year.
Growth was seen across instruments, consumables, and services, with notable strength in the XM/XcytoMatic platform.
Cost control remains strong, benefiting from last year's restructuring.
Product development of the XM50/XcytoMatic 50 and Sample Management System progressed as planned, with positive customer feedback at a major industry conference.
Financial highlights
Instrument sales were DKK 40 million, with XM accounting for about half; instrument sales grew by 4% year-over-year.
Consumables revenue was DKK 55 million, up 12% year-over-year; services grew 4% (9-10% in constant currency).
LCB (Life science research, Cell and gene therapy, Bioprocessing) accounted for 94% of total Q1 revenue.
Gross margin improved due to a higher XM sales mix.
U.S. tariffs had minimal impact, costing less than $1 million in the quarter.
Outlook and guidance
Upgraded guidance reflects increased interest in the XM/XcytoMatic platform, not a single large order.
Full-year 2025/26 revenue is expected in the DKK 565-580 million range, with EBITDA projected at DKK 320-335 million.
Expectation of ramping up XM sales, with larger orders anticipated by fiscal year-end.
Guidance is based on a broad pipeline, not reliant on any single customer or order.
Profitability is expected to improve, with stable margins and targeted investments in software and sales talent.
XcytoMatic sales matching NucleoCounter: implications?
Capitalize on cell therapy automation trend
US/Canada growth vs Europe: underlying factors?
What is the expected XM to NC replacement ratio?
Outline XM Octopus software revenue model and timing
Assess bioprocessing market penetration strategy
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next ChemoMetec earnings date
Q2 20264 Feb, 2026
Next ChemoMetec earnings date
Q2 20264 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Producer of cell counting and analysis systems
ChemoMetec is a Danish biotech company that specializes in the development and production of cell counting and analysis systems for use in the life sciences industry. The company was founded in 1997 and has since become a leading provider of advanced cell analysis solutions to customers around the world. Some of ChemoMetec’s competitors include Thermo Fisher, MERCK, and GE Healthcare.
The business model
ChemoMetec's business model is based on providing high-quality, reliable, and easy-to-use cell analysis systems that enable researchers to obtain accurate and reproducible results. The company's products include the NucleoCounter and NC-202 instruments, which are used by researchers in a variety of applications, including drug discovery, cancer research, and stem cell research.
How ChemoMetec makes money
ChemoMetec generates revenue primarily through the sale of its cell analysis systems, as well as through ongoing customer support and service contracts. The company's revenue is also generated through its partnerships with other biotech and life sciences companies, as well as through collaborations with academic research institutions.
Accurate cell counting and analysis
ChemoMetec's cell analysis systems have gained a reputation for their accuracy and reliability, with a high degree of precision in cell counting and analysis. The company has also been recognized for its user-friendly approach to design and software, making their systems easy to operate and accessible to a wide range of researchers.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage